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ABSTRACT 
This study aims to validate the preparation approach of novel biodegradable  
polymer-bioactive ceramic composites of poly (lactic acid) (PLA), chitosan (CS), and tricalcium 
phosphate (TCP) and evaluate their suitability for Guided Bone Regeneration (GBR). GBR is a 
dental surgical procedure that uses barrier membranes to direct the growth of new bone tissues. 
Resorbable membranes eliminate the need for a second surgery that patients with non-resorbable 
membranes need. Cryomilling, a solid-state, low-temperature blending process, facilitates bulk 
fabrication by eliminating difficulties such as high viscosity, insolubility and long processing 
times. It is a cost-effective technique to generate particles with high surface area to volume ratio, 
which provide a larger area for biological activity. Electrospinning was used to fabricate fibrous 
barrier membranes using the biocomposites prepared by cryomilling. X-Ray Diffraction (XRD) 
and Differential Scanning Calorimetry (DSC) were utilized to characterize the molecular 
structures, identify the glass transition and melting temperatures and to confirm the occurrence of 
homogeneous polymer-ceramic biocomposites. Scanning Electron Microscopy (SEM) was used 
to observe the morphology of the powder composites and the electrospun membranes. RAW 264.7 
murine macrophages were used to evaluate the cytocompatibility of the biocomposites and 
quantitatively analyzed with CellTiter-Blue® (CTB®) cell viability assay. Also, MG63 cells were 
seeded on electrospun membranes to quantify the capability of the biocomposites to encourage 
cell proliferation. Coherent anti-Stokes Raman Spectroscopy (CARS) and brightfield (BF) 
microscopy were used to analyze cell proliferation on the seeded membranes qualitatively. A 21-
day In vitro degradation studies were performed and analyzed using Raman spectroscopy. CTB® 
cell viability assay carried out on the electrospun membranes revealed that the cells are viable and 
xv 
 
 
metabolically active both at 3 and at 7 days from cell seeding indicating the suitability of the 
material for GBR. 
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CHAPTER I 
GENERAL INTRODUCTION 
1.1. Research Motivation 
In the recent years, the increasing interest in developing dental procedures for bone 
regeneration has been a consequence of the growing number of patients in need of such 
interventions. Based on the data from the 2009 and 2010 National Health and Nutrition 
Examination Survey (NHANES), Eke et al. (2012) reported that 64.7 million adults in the United 
States (U.S.) suffer from periodontitis with varying levels of severity [1]. The results of similar 
surveys only reiterate the prevalence of periodontitis and have rightly warranted attention from the 
scientific community [2-4]. 
Periodontitis is a dental disease that is characterized by the destruction of the connective tissue 
and dental bone support due to an inflammatory response to the infection caused by the activity of 
anaerobic bacteria [5, 6]. Today, periodontists use a wide variety of techniques to treat this 
condition depending on the tissue affected and the severity of damage caused to the tissues. Some 
of the common methods used are laser treatment, gum graft surgery, non-surgical treatment such 
as scaling and root planing, dental crown lengthening, pocket reduction procedures and dental 
implants [7]. However, over the past few decades, regenerative techniques have received 
significant attention for restoring the functionality and structural integrity of a diseased 
periodontium, as it could potentially solve problems such as shortage of bone grafts and graft 
rejection [8-13].  
Guided Bone Regeneration (GBR) is a surgical technique in dentistry that makes use of barrier 
membranes to exploit the inherent regenerative capability of the human body [14]. GBR has been 
able to treat various bone defects caused by periodontitis [15]. In principle, GBR uses barrier 
2 
 
 
membranes to prevent the entry and proliferation of non-osteogenic cells into defect sites and to 
permit the growth of osteogenic cells selectively [16]. Therefore, the success of the procedure, 
amongst other factors, is also largely governed by the design and performance of the barrier 
membrane. A suitable membrane has to be biocompatible, mechanically stable and flexible during 
the time of implantation [17].  
The engineering community has been particularly interested in the development of new 
materials that could be utilized for the fabrication of barrier membranes. The number of scientific 
papers focusing on the production and evaluation of new membrane materials is a testament to the 
potential in this area [18-22]. Despite this, the “ideal” membrane has not yet been fabricated. 
Expanded polytetrafluoroethylene (e-PTFE) has by far been the most preferred material for the 
fabrication of non-resorbable membranes [23-30]. However, it has been shown that patients are 
exposed to infections when they undergo surgeries for the removal of non-resorbable membranes 
[31, 32]. Resorbable membranes have played the role of alternatives by eliminating the need for 
removal surgeries [33]. Natural polymers like chitosan, collagen and synthetic polymers like poly 
(lactic acid) (PLA), polycaprolactone (PCL), poly (lactic-co-glycolic acid) (PLGA) have been used 
individually or in blends for the fabrication of barrier membranes [34-44]. In the recent years, the 
addition of bioactive ceramics has been used to improve the mechanical properties and cell affinity 
of barrier membranes [45, 46]. Composite materials have thus offered researchers an opportunity 
to fabricate tailor-made membranes for specific applications.  
This study intends to validate the fabrication approach of novel biodegradable  
polymer-bioactive ceramic membranes for use in GBR. A low-temperature, solid-state, blending 
technique called cryomilling was used to generate composites made up of PLA, CS, and TCP. As 
mentioned previously, PLA has produced considerable success when used for GBR applications. 
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CS, apart from being resorbable and biocompatible, was also chosen for its antimicrobial 
properties [35]. The role of CS in cell adhesion, proliferation, and osteoblast differentiation has 
been well documented [36-38]. TCP was used as a synthetic bone substitute material to induce the 
regeneration of bone tissue [39-41]. PLA and CS have very different polarities and hence achieving 
a compatible blend of these materials pose a challenge [47]. Moreover, when TCP is dissolved in 
solvents for processing, rheological properties limit it’s loading, with the aggregation and 
delamination occurring at high loading percentages [48]. This study validated the potential of 
cryomilling to overcome such limitations associated with the fabrication of biocomposites. 
 XRD was used to confirm the occurrence of a homogeneous composite powder blend. DSC 
was utilized for the thermal characterization of biocomposites prepared by cryomilling. The 
cytotoxicity of the biocomposites was evaluated using RAW 264.7 murine macrophages. The cell 
viability was investigated using CTB® cell viability assay at the end of 24 and 48 h from the time 
of cell seeding. The cell morphology was qualitatively evaluated using BF microscopy. The 
powder composites were then spun into nanoscale fibers using electrospinning. SEM was used to 
observe the morphology of the fibers generated. CTB® cell viability assay was used to evaluate 
the proliferation of MG63 cells on electrospun membranes quantitatively. A live/dead viability 
assay was conducted, and the fibers were qualitatively analyzed using CARS and fluorescence 
microscopy. Also, a 21-day In vitro degradation study was performed on the electrospun 
membranes and analyzed using Raman spectroscopy. All data are expressed as mean values along 
with minimum and maximum values. Statistical analysis was carried out using Tukey’s post hoc 
test of two-way Analysis of Variance (ANOVA) with PRISM ver. 7.0 software. Values of p<0.05 
were taken to indicate statistical significance.  
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In conclusion, the goal of this research study is to fabricate fibrous membranes made out of 
cryomilled PLA/CS/TCP biocomposites that will stimulate the regeneration of the alveolar bone 
tissue. 
 
THESIS ORGANIZATION 
In this thesis, Chapter 1 presents the general introduction and information of this study. 
Chapter 2 provides the motivation behind this research by presenting significant background 
information on certain key topics. Chapter 3 intends to provide a brief summary of various 
observations that were made during the pilot studies, and it also presents the logical reasoning for 
the modifications made in the experimental design. Chapter 4 illustrates the detailed experiment 
design and implementation, together with results and conclusions about the suitability of the 
generated biocomposites for GBR. Chapter 5 provides general findings and future research 
directions. Appendix A describes briefly the statistical analyses that were performed to analyze 
the data obtained from in vitro studies. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
This section intends to discuss the motivation behind this research by providing significant 
background information on certain key topics related to this study. The rationale behind the design 
and development of this research study has been provided along with inferences from important 
research works published on the subject of interest.  
This section is divided into six parts: 1) Periodontitis, 2) Guided Bone Regeneration,  
3) Materials for barrier membranes, 4) Fabrication of polymer blends, 5) Production of polymeric 
nanofibers, 6) Summary of literature 
 
2.1. Periodontitis 
2.1.1. Periodontitis 
Periodontitis is a dental disease that is characterized by the destruction of connective tissue 
and dental bone support due to an inflammatory response to the infection caused by bacteria  
(Fig. 1) [5, 6]. Periodontitis is a degenerative disease that starts 
off with a reversible condition known as gingivitis which is 
characterized by the inflammation of the gums. The continuous 
build-up of plaque and tartar is responsible for the formation of 
pockets between the gums and the teeth. These pockets act as 
breeding grounds for bacteria and cause the inflammation of the 
gums. When left untreated, gingivitis can progress to an 
advanced stage and cause periodontitis. Periodontitis, unlike 
Fig. 1. Progression of periodontitis1  
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gingivitis, is an irreversible condition that leads to the destruction of periodontal tissues and, 
eventually, tooth loss [11].  
 
2.1.2. Prevalence of Periodontitis 
Currently, 5-20% of the adult population worldwide suffer from severe periodontitis which 
can ultimately result in tooth loss [49-51]. Based on the data from the 2009 and 2010 National 
Health and Nutrition Examination Survey (NHANES), Eke et al. (2012) reported that 64.7 million 
adults in the United States (U.S.) suffer from periodontitis with varying levels of severity [1]. It 
has also been understood that children and adolescents can also suffer from different forms of 
periodontitis ranging from aggressive to chronic periodontitis [52-54]. Moreover, the data from 
National Institute of Dental and Craniofacial Research (NIDCR, National Institutes of Health, 
U.S.) suggests that about 90% of adult populations more than 70 years old suffer from at least a 
moderate level of periodontal disease [2-4]. The high-level prevalence of periodontitis can be 
attributed to its association with several systemic disorders.  
 
2.1.3. Risk Factors 
Over the years, researchers have conducted numerous studies to understand the different 
factors that can influence the possibility of periodontitis. These risks have been broadly classified 
into two distinct categories namely modifiable and non-modifiable risk factors. The presence and 
accumulation of bacterial species have been identified as the major modifiable risk having a 
significant influence in increasing the risk of periodontitis. Bacteroides forsythus, Prevotella 
intermedia, Peptostreptococcus micros and Fusobacterium nucleatum have been strongly linked 
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to the progression of periodontitis in adults [55-58]. The other modifiable risks include smoking, 
diabetes mellitus, cardiovascular disease, stress, and obesity [59-69]. Osteoporosis, female 
hormonal alterations, pregnancy, host response, and age have all been identified as  
non-modifiable risk factors that have a significant correlation with periodontitis [70-73]. 
 
2.1.4. Mechanism of Bone Resorption: Understanding Periodontitis 
Periodontitis affects the structural integrity of the periodontal tissues. The periodontium 
consists of the root cementum, alveolar bone, periodontal ligament and the dentogingivial junction 
(Fig. 2). Each of these components have individual and distinct 
roles to play to maintain the overall function of the periodontium. 
A person suffering from a periodontal disease will experience a 
progressive destruction of the periodontium. Researchers have 
also been always working on decoding the mechanism of bone 
resorption in periodontitis to design effective treatment 
techniques. It has now been widely accepted that the loss of 
alveolar bone is a natural consequence of the progression of 
periodontitis. The loss of the alveolar bone results in the formation of a pocket around the tooth 
which then acts as a reservoir supporting the growth of anaerobic bacteria which in turn leads to 
tooth loss [74]. After studying the mechanism of bone resorption, Heinz et al. (2015) concluded 
that “The Th1-type T lymphocytes, B cell macrophages, and neutrophils promote bone loss 
through upregulated production of proinflammatory mediators and activation of RANK-L 
expression pathways” [75]. This response disturbs the delicate balance between protective and 
destructive functions of the immune system [76-81].  
Fig. 2. Cross-sectional image of the periodontium2  
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2.1.5. Treatment Options 
Periodontists use a wide variety of techniques to treat patients suffering from gingival recession 
and periodontitis depending on the severity of the condition. Some of the common methods used 
are laser treatment, gum graft surgery, non-surgical treatments, dental crown lengthening, pocket 
reduction procedures and placement of dental implants. Recently, engineers and periodontists have 
been particularly interested in regenerative processes that make use of barrier membranes to restore 
the functionality and structural integrity of a diseased periodontium. At this point, it is imperative 
to understand that regenerative procedures do not act as a treatment for periodontitis. Rather, it is 
an engineered approach for regenerating defects that have been caused by periodontitis. Therefore, 
appropriate periodontal treatment needs to be administered before regeneration is initiated [82].  
In the recent years, the developments in the field of regenerative medicine have made engineers 
and clinicians believe that these procedures could be used to exploit the inherent regenerative 
capabilities of the human body. It is believed that regeneration techniques could solve the problem 
of shortage of bone grafts and challenges associated with graft rejection [12, 13, 83]. Therefore, in 
this particular study, the focus will be on regenerative surgical modalities that have been used to 
regenerate diseased tissues. 
 
2.2. Guided Bone Regeneration 
2.2.1. Bone Augmentation 
Typically, patients with loss of teeth due to periodontitis need to undergo an implant 
therapy to fill an edentulous site. It is now widely accepted that the end goal of an implant therapy 
is to provide a completely functional implant that also caters to the aesthetic expectations of the 
person undergoing the treatment. However, a successful implant therapy demands an alveolar 
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ridge with appropriate dimensions to ensure success of the procedure. Researchers have concluded 
that tooth extraction can result in greater resorption leading to severe loss of alveolar width [84-
86]. It has also been shown that, without treatment, post tooth-removal, crestal bone resorption is 
unavoidable 87, 88]. Therefore, it is important to have an intermediate step for the regeneration of 
alveolar deficient sites prior to implant placement. This need has necessitated the development of 
materials and techniques that can provide predictable and reliable results [89]. Researchers have 
developed and tested different treatment modalities such as ridge augmentation before implant 
placement, immediate implant placement in fresh extraction sockets, ridge augmentation with 
implant placement and ridge augmentation in combination with implant placement [90-99].  
 
2.2.2. Guided Bone Regeneration  
Guided Bone Regeneration treatment is based on the idea that alveolar and mandibular 
bone defects can be regenerated by using barrier membranes, which can mechanically isolate the 
defect site from non-osteogenic cells and selectively support the growth of osteogenic cell 
populations (Fig. 3) [14]. Approximately 60 years ago, the concept of secluding an anatomic site 
with the aim to promote healing was introduced, when cellulose acetate fibers were used to 
regenerate damaged nerves cells and tendons [100, 101]. Around the same time, in a different 
study, researchers reported enhanced wound healing of rib, 
femoral and radial bone defects by using barrier membranes 
[102, 103]. Later on, favorable results were reported by placing 
barrier membranes over jawbone defects in rabbits and cranial 
defects in rats [104, 105]. All these experimental studies 
reinforced the belief in the idea of GBR which was first Fig. 3. Application of a barrier membrane
3 
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introduced in a work published by Dahlin et al. (1988) [10]. Over the years, researchers have built 
on the foundation laid by these initial studies and have successfully used the concepts of material 
chemistry to develop efficient membranes. Currently, GBR is one of the most promising treatments 
available for patients to regain sufficient bone volume at the implant site [14, 106-108]. The 
occlusive membranes used in this treatment method promote the growth of new bone tissue by 
acting as a scaffold [109]. Clinically, it has been claimed that the barrier membranes used for the 
treatment should support new bone formation and maturation for at least six weeks [110, 111]. 
Hence, it is important to design and fabricate occlusive membranes with optimal persistence and 
stability to guarantee the success of the procedure.  
 
2.2.3. Barrier Membranes 
For the GBR technique, irrespective of the use of bone graft material, the barrier membrane 
has been proven to play a vital role in the prevention of epithelial tissue migration into the defect 
site, and in consequently allowing sufficient time for bone, cementum and ligament regeneration 
[112, 113]. The occlusive membranes are broadly classified into resorbable and non-resorbable 
membranes based on their ability to degrade inside the human body. The non-resorbable 
membranes made out of expanded polytetrafluoroethylene (e-PTFE) have been extensively studied 
and are still considered the gold standard in the industry [114]. However, in the recent years, 
researchers have shown tremendous interest in fabricating resorbable membranes because it 
eliminates the need for a removal surgery which is required in the case of their non-resorbable 
counterparts [11, 115]. The use of resorbable membranes has made the procedure less traumatic 
for the patients undergoing the treatment. Moreover, it has been suggested that the stiff non-
resorbable membranes may result in soft dehiscence and subsequently progression of infection 
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[116]. However, as far as resorbable membranes are concerned, there are still challenges that need 
to be addressed such as rapid degradation of the membrane, lack of structural integrity and reduced 
osteoconductivity [117]. One of the significant challenges with the resorbable membrane has been 
to match its resorption time with the rate of tissue formation [118]. In conclusion, ideal barrier 
membranes for GBR need to exhibit: a) mechanical strength, b) biocompatibility, c) clinical 
manageability, d) osteoconductivity and preferably e) a degradation rate that matches the rate of 
bone tissue formation [11, 119-121]. Over the years, researchers have experimented with a wide 
variety of materials for the fabrication of GBR membranes. 
 
2.3. Materials for Barrier Membranes 
2.3.1. Materials for Non-resorbable Membranes 
The most regularly used materials to make non-resorbable membranes are expanded high-
density polytetrafluoroethylene (e-PTFE) and titanium reinforced high-density 
polytetrafluoroethylene (Ti-d-PTFE) [122]. PTFE based membranes have been studied extensively 
and are especially noted for their excellent space-making ability [123]. A favorable correlation 
between space protection and bone regeneration has also been established [124]. These 
biocompatible and inert membranes are known to maintain their structural integrity. Amongst the 
two membrane materials, the titanium reinforced material has been shown to exhibit superior 
mechanical strength. Moreover, the increased mechanical strength allows the membrane to handle 
better the compressive forces exerted by the surrounding soft tissue and hence improves the 
regenerative capacity of the membrane [125]. The biggest drawback with non-resorbable 
membranes is that a second surgery is required to remove the membranes which implicate not only 
new pain but also economic discomfort [117].  
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2.3.2. Natural Materials for Resorbable Membranes 
Biodegradable membranes are commonly made up of either natural or synthetic polymers. 
Amongst natural polymers, the commonly used ones are collagen and chitosan (CS). The other 
commonly used natural materials are gelatin and silk fibroin (SF). This section discusses each of 
these materials along with some of the important scientific observations that have been published. 
 
2.3.2.1. Collagen-based Membranes. Collagen is a major component of the Extra Cellular Matrix 
(ECM) and hence has repeatedly been used due to its biocompatibility and good cell affinity [126-
128]. Collagen membranes, majorly type I and type III, have favorable properties like fast 
vascularization, minimum immune response, good tissue integration, osteoblastic adhesion and a 
capability to promote wound healing [118, 129-134]. Despite having such favorable properties, 
the use of collagen-based membranes has been limited because of certain fundamental drawbacks. 
Firstly, Type-I collagen is considered to be expensive. Also, collagen-based membranes have 
demonstrated a poor space-making ability in humid conditions, inferior mechanical strength and 
they possess a degradation rate that is hard to control [135]. Additionally, it has also been suggested 
that these membranes have shown poor mechanical properties during their degradation [136]. It 
has been suggested that different cross-linking techniques can be used to improve the stability and 
biomechanical properties of collagen-based membranes [137-140]. Although techniques like 
cross-linking give certain incentives to use collagen for the fabrication of membranes, they 
introduce other problems such as prolonged integrity and reduced capability to cause angiogenesis 
[141-143]. Research also indicated that cross-linked membranes could cause adverse events and 
reduced bone regeneration in comparison to the non-crosslinked membranes [144]. Unlike 
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synthetic materials, collagen is derived from human or animal tissues. Hence, there is also an 
increased risk of infections.  
 
2.3.2.2. Chitosan-based Membranes. CS is another natural polymer that has shown great potential 
to be used in the fabrication of barrier membranes. CS is a polysaccharide obtained by the 
deacetylation of chitin and has many applications due to its biochemical properties like 
antimicrobial effects, biodegradability, biocompatibility, and non-toxicity [145, 146]. CS is 
derived from shells of crustaceans, a natural resource and hence exhibits minimal foreign body 
response unlike polymers derived from mammalian proteins [147, 148]. It has been suggested that 
modified CS scaffolds demonstrate osteoconductivity in surgically created bone defects [149]. The 
antimicrobial and wound healing properties of CS has been attributed to its cationic nature [150]. 
Shin at al. (2005) suggested that the CS membranes were compatible with cells in in-vitro 
environments and also documented its role in bone regeneration [33]. Moreover, it has been proven 
that CS plays a supporting role in cell proliferation and osteoblast differentiation making it an 
attractive scaffold material for bone regeneration [43-45, 151]. However, the drawback of CS is 
its inferior mechanical properties which limit its use in load-bearing applications [152]. Over the 
years, researchers have found ways to work around this limitation. CS’s attractive biomedical 
properties can be exploited by blending it with other synthetic polymers and ceramic materials to 
enhance its bioactivity and mechanical properties [153]. CS has been cross-linked with genipin to 
improve its immunogenicity and reduced mechanical properties. Researchers have reported faster 
healing time, superior mechanical properties and earlier infiltration timings with the use of such 
cross-linked CS membranes [154-156]. One of the significant contributing factors for the shift in 
attention towards CS is its low cost due to its large-scale availability in nature [157-160]. 
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2.3.2.3. Gelatin-based Membranes. Gelatin is a soluble protein that is derived from partially 
denatured collagen. Just like chitosan, factors like availability and cost efficiency have encouraged 
researchers to use gelatin as a scaffold material [161]. Gelatin has been used in both guided tissue 
regeneration (GTR) and GBR applications owing to its attractive properties such as good cell 
adhesion, low immunogenicity, and biocompatibility [162]. However, fast degradation and poor 
mechanical properties have also been reported about gelatin. To combat these limitations, cross-
linking with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), cross-linking with N-
hydroxyl succinimide (NHS), glutaraldehyde treatment (GTA) and heat treatment has been used 
in the past [163-165]. It has been reported by Zhang et al. (2011) that the enhancement in elastic 
properties of gelatin is usually accompanied by a low Young’s modulus hence limiting the use of 
gelatin in GBR and GTR membranes [163]. 
 
2.3.2.4. Silk Fibroin-based Membranes. SF is a natural protein that is extracted from silkworms or 
spiders, and it possesses properties that are expected of a scaffold material used in regenerative 
applications [166]. Some of its advantageous properties include excellent biocompatibility, oxygen 
permeability and biodegradability [167]. Kim et al. (2005) reported a complete union in calvarial 
defects of rabbits treated with SF based membranes. It was also said that SF provides incredible 
strength that improves the space-making ability of the scaffold [168]. In another independent 
study, the tensile strength of SF-based membranes was shown to be better than cross-linked 
collagen and PTFE membranes [169]. Even though there is considerable evidence that SF could 
be a potential candidate for the fabrication GBR scaffolds, it is slightly more expensive in 
comparison to CS. Moreover, SF demands a tedious preliminary processing before its use in 
biocomposite fabrication, unlike CS. 
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2.3.3. Synthetic Materials for Resorbable Membranes 
In an attempt to overcome the inherent shortcomings of natural polymers, researchers have 
been working on using synthetic polymers in scaffold fabrication for regenerative medicine and 
drug delivery applications [98, 170-177]. The most commonly used synthetic polymers include 
polycaprolactone (PCL), poly (lactic acid) (PLA), poly (glycolic acid) (PGA) and poly (lactic-co-
glycolic acid) (PLGA) [178-181]. Favorable properties like biocompatibility, biodegradability, 
clinical flexibility and commercial availability explain the increased usage of polyester-based 
membranes in tissue engineering applications [111, 135, 182].  
 
2.3.3.1. PLA-based Membranes. PLA has been widely used for the fabrication of sutures, drug 
delivery systems, and scaffolds for tissue engineering [183, 184]. It has been suggested that PLA 
has been of great interest to biomedical and tissue engineers because of its hydrolysable ester bonds 
[185]. However, poly (L-lactic acid) (PLLA) has a degradation rate that is not favorable for the 
use in GBR. It takes about four years to degrade while the ideal membranes should be completely 
resorbed in under one year [186, 187]. To overcome this difficulty, researchers have often used 
copolymers of lactide and e-caprolactone, glycolide and other polymers to reduce the time taken 
for complete resorption. Vivosorb®, a commercially available membrane consisting of poly (D, L-
lactide-e-caprolactone) was reported to be suitable for the purpose of regeneration with favorable 
properties like biocompatibility and non-cytotoxicity. Vivosorb® takes approximately 16 months 
to be completely resorbed [188]. Epi-Guide® is another resorbable, commercially available 
membrane consisting of poly (D, L-lactic acid) (PDLLA) with a unique three-layer technology 
that is known for its space-maintenance ability. Epi-Guide® maintains its structure and functions 
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for five months after implantation with a complete resorption in just over a year [189, 190]. Poly 
(lactic-co-glycolic-acid) has also been studied extensively in the past few decades [191].  
 
2.3.3.2. PLGA-based Membranes. PLGA is similar to PLA regarding degradation mechanism 
where the hydrostatically unstable bonds hydrolyze into lactic acid and glycolic acid [192]. 
Resolut® is a commercially available product consisting of two layers where one layer prevents 
the growth of epithelial tissue while the other layer promotes the integration of tissues. Histological 
studies have shown that this product is as effective as non-resorbable membranes with regards to 
performance but with the additional benefit of being resorbable [193, 194]. Recently, Hua et al. 
(2014) have shown that PLGA based membranes can assist the formation of new bone trabeculae 
in beagle dogs [38]. The stiffness of PLGA membranes was a major problem until it was resolved 
with the addition of softeners like N-methyl-2-pyrrolidone (NMP). Some of the studies indicate 
that the addition of softeners could also accelerate the maturation of preosteoblastic cells and bone 
regeneration [195, 196]. The addition of lauric acid has also been suggested to improve the 
mechanical properties of pure PLGA membranes [197]. 
 
2.3.3.3 PCL-based Membranes. PCL has been an attractive option for tissue engineers trying to 
design scaffolds because of its low cost, high mechanical strength and excellent biocompatibility 
[198-200]. However, due to its slow resorption rate, its use in GBR membranes has been limited 
[18, 201, 203]. The benefit of using PCL lies in the fact that it does not produce an acidic 
environment during degradation. In spite of having decent properties, PCL is mostly blended or 
co-polymerized with other polymers before its use in scaffold fabrication. 
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2.3.4. Ceramic Additives 
The primary goal of GBR is to use scaffolds to permit and promote the growth of the ECM 
and eventually support ossification. The presence of phosphate and calcium within the local 
environment is necessary to achieve this goal [203]. Ceramics such as calcium phosphate 
(biphasic) (CaP), TCP and hydroxyapatite (HA) have been widely employed in the scaffold 
fabrication process to make the scaffold resemble the mineral components of the human bone 
[109]. Other ceramics used for bone regeneration include bioactive glass, glass-ceramic, titanium 
and silica [153, 204-207]. The increasing use of bone substitute materials can be attributed to the 
inherent drawbacks of the autografting procedure such as donor site morbidity and limited 
availability of donor sites [208]. The different forms of calcium phosphates are used based on the 
crystal structure and dissolution rate required for that particular application [209]. Calcium 
phosphates have been shown to enhance osteoblast response thus improving the overall biological 
response to the fabricated scaffolds [210-212]. Researchers have successfully used different 
fabrication techniques such as electrospinning and electrospraying to add various forms of calcium 
phosphates to the scaffold to increase its bioactivity, adhesive and proliferative capabilities [37, 
127, 213-218]. TCP has also been proven to be an ideal synthetic bone substitute material to induce 
the regeneration of bone tissue [219-221]. Koyama et al. (2004) showed that TCP increased bone 
regeneration 12 weeks after surgery [126]. Copolymerized PLA (CPLA) and TCP were prepared, 
and they were reported to have good biocompatibility with excellent mechanical properties [42]. 
Moreover, it provides calcium ions to the bone tissue to create a suitable ionic environment that 
will encourage bone formation [46, 222].  Jansen et al. (1995) fabricated HA-based composites 
and reported its excellent biocompatibility [223]. Even though the addition of ceramic additives 
has yielded scaffolds with better proliferative capabilities, ceramic addition has always been 
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limited to minuscule amounts due to processing and mechanical strength considerations [224, 
225]. 
 
2.3.5. Membranes based on Polymer Blends  
As GBR membranes require a broad variety of properties to succeed in regenerating the 
alveolar bone, it is almost impossible for a single material to be successful. For example, natural 
polymers almost always lack mechanical strength while synthetic polymers are not capable of 
inducing biological activity. It may be an efficient solution to blend different materials to hinder 
their drawbacks and showcase positive synergistic effects [18]. To combat the weak mechanical 
properties of PLGA, it was mixed with PCL in the same ratio, and their compressive strength and 
modulus were found out to be much higher than pure PLGA scaffolds [201]. It has also been 
suggested that PDDLA/PLGA composite scaffolds could serve as a barrier for tissue regeneration 
[202]. Besides the composites mentioned in this section, other synthetic blends may also have a 
bright future in GBR procedures [226, 227]. As far as natural polymers are concerned, a significant 
amount of research has been done to blend CS with other polymers to improve its mechanical and 
physical properties. For example, it was reported that the cell adhesion and proliferation of 
chitosan could be increased by blending it with gelatin [228]. Another study observed the effects 
of adding HA to the gelatin/CS membrane and reported that the membrane possessed sufficient 
mechanical and structural properties to be suitable for GBR [229]. On the other hand, natural 
polymers have also been blended with synthetic polymers to improve the properties of the 
synthetic polymers when used for GBR [230-234]. For example, PLLA/CS membranes have 
shown much better degradation characteristics and non-fibroblast penetration properties when 
compared to pure PLLA membranes [235]. Another study indicated that the incorporation of CS 
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into PCL-PEG membranes improved the collagen orientation of the regenerated periodontium 
[236]. Antibacterial agents and growth factors have been the other exciting additions to polymers 
[237]. 
Over the years, different techniques have used to blend materials together in order fabricate 
polymer blends and composite materials. However, the blending technique needs to be evaluated 
and chosen based on certain considerations such as materials to be blended, final application of 
the blend, processing time, economic feasibility, and, most importantly the efficiency of the 
process. 
 
2.4. Fabrication of Polymer Blends 
As mentioned in the previous sections, polymer-bioceramic composite scaffolds represent 
a convenient alternative for applications in hard tissue regeneration due to the possibility to tailor 
their various properties such as mechanical, structural behavior, degradation kinetics and 
bioactivity [238]. However, the inherent immiscibility of polymers and composites pose a 
challenge to the success of the material in bone tissue engineering (BTE) as the rheology of the 
dispersed phase might play a critical role in determining the manufacturability of scaffolds [239]. 
This section intends to discuss some of the compatibilization techniques commonly used in 
polymer processing. 
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2.4.1. Melt Mixing with Block Copolymers 
Block polymers have repeatedly been used for the 
compatibilization of immiscible polymer blends, and their 
success has been well documented [240-242]. It has been 
shown that block polymers are thermodynamically 
favored to bridge the interface of immiscible polymer 
blends (Fig. 4). A few other kinds of polymers such as 
alternating, graft and gradient copolymers have also been used for similar applications. However, 
their usage remains limited as result of reduced commercial availability [243, 244]. Block 
copolymers have been observed to compatabilize immiscible blends by increasing the steric 
hindrance of domain motion and decreasing surface tension at the interface [245]. It has also been 
shown that larger copolymers exhibit improved compatibilization properties due to increased 
entanglement in both domains [246]. In general, it is believed that 5% of the dispersed phase 
interface must be saturated with block copolymer to prevent dynamic coalescence, while 20% 
would impart static stability [247]. Even though the success of this technique has been well 
documented, there have been issues that have repeatedly been reported about block copolymer 
compatibilization. One problem that has been reported in the literature is the self-assembling 
behavior of copolymers into micelles within the matrix phase [247]. Additionally, it has been 
reported that these micellar structures act as a contaminant and ultimately reduce the degree of 
compatibilization [248]. Another problem has been the necessary compromise that has to be made 
between using larger, efficient copolymers and diffusion problems associated with larger 
molecules. These issues are overcome by generating block copolymers within materials during 
processing at the blend interface [246]. However, this technique also has limitations such as 
Fig. 4. Use of block copolymers in stabilizing the interface4  
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increased operating costs and slow reaction kinetics [249]. Moreover, this method is usually 
employed during melt mixing which uses high temperatures which could result in the denaturing 
of bioactive molecules [250].  
 
2.4.2. Common Solvent Method 
In this technique, two incompatible polymers are dissolved in a common solvent, either 
under ambient or elevated pressures and temperatures. After complete dissolution, the solvent is 
removed by freeze drying or sublimation [251]. Unfortunately, this technique has several 
limitations and challenges, especially in the tissue engineering application. Homogeneous 
blending is a primary challenge during high loadings of filler materials [252]. The common solvent 
needs to be identified diligently as the incomplete dissolution of the polymers can reduce the 
efficiency of the process [253]. The use of toxic solvents has been shown to affect the 
biocompatibility of the materials involved [239]. The limitations mentioned above necessitate the 
development and use of low-temperature, solid-state techniques for the processing of 
biocomposites. 
 
2.4.3. Cryomilling 
Cryomilling is a novel technique for alloying, but its advantages as a biomaterial 
fabrication method have yet to be leveraged on in the area of biocomposite fabrication [250]. It is 
the mechanical attrition of particles under a cryogenic environment. In material processing, it has 
often been used as a technique to strengthen the materials through grain refinement and dispersion 
of fine, nanoscale particles, mostly employed in the creation of dispersed metallic phases [254, 
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255]. Zhu et al. (2006) prepared polyaniline/iron composites using cryomilling [253]. Hou et al. 
(2012) have reported the fabrication and characterization of metal/ceramic powders [256]. 
However, in the recent years, researchers have used cryomilling to blend immiscible materials and 
generate mixtures which otherwise would have been difficult to produce [48]. As mentioned in the 
previous sections, there is a need to combine synthetic polymers with other materials like natural 
polymers and bioactive ceramics to elicit desirable biological responses from the human body. 
However, the blending of these materials is mostly achieved by dispersing the bioactive 
ingredients as the second phase in polymers solutions or melts [238, 239, 257, 258]. Some of the 
drawbacks to these traditional techniques include the phase separation of additives during blending 
which ultimately results in an inefficient blend. Also, it has been suggested by Coroller et al. (2013) 
that the homogeneity of dispersion is crucial to attaining superior mechanical performances from 
composite materials [259]. Polymer powder processing has previously been used for fabrication 
of pharmaceutical coatings and scaffolds for tissue engineering [260, 261]. Cryomilling has been 
used to create homogeneous blends of polymeric materials for the preparation of tissue engineering 
scaffolds [252]. Another study has shown that cryomilling can be utilized for the fabrication of 
biodegradable PCL/PGA scaffolds [262]. Apart from assisting with the manufacture of 
homogeneous blends, cryomilling also offers other benefits that cannot be expected of other 
traditional processing techniques. Cryomilling provides the benefit of producing a finer grain 
structure in relatively shorter processing times [263]. Researchers have found that particles with 
high surface area to volume ratio provides a larger area for biological activity [264]. Recently, Lim 
et al. (2014) fabricated PCL/TCP composite powders by cryomilling for tissue engineering and 
reported that cryomilling was able to achieve homogeneous dispersion even at higher loading 
percentages of ceramic particles [48]. Moreover, cryomilling requires lesser energy to induce a 
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material fracture when compared to other milling techniques as the whole process takes place 
below the glass-transition temperatures of the polymers used. In addition to all the advantages that 
have been previously mentioned, cryomilling is one method that can be used to overcome the creep 
behavior faced by polymeric scaffolds. By incorporating nanomaterials, it has been postulated to 
extend the viscoelastic response, resulting in high resistance to time-dependent strain results. 
Hence, it has been considered that the future of polymer biocomposites for utility in scaffold-based 
BTE lies in achieving homogeneous blends with exceptional mechanical properties [239]. 
 
2.5. Production of Polymeric Nanofibers 
Tissue engineers have made extensive use of polymeric nanofibers for the purpose of tissue 
regeneration. The popularity of nanofibers can be understood by taking a look at the number of 
reviews focusing on their production, application, and interaction with biological cells [265-269]. 
The unique properties of polymeric membranes have made them an indispensable tool in the 
armory of a tissue engineer. The small diameter of these fibers closely matches the size and 
morphology of the ECM fibers. In general, electrospun fibers are used as biomimetic scaffolds, 
and their high surface area to volume ratio have only added to their advantages in the field of drug 
loading and regenerative medicine [270-272]. These unique properties have been extremely useful 
in modulating cell behavior [273]. Three production techniques are commonly employed for the 
fabrication of nanofibers in the field of tissue engineering. This section will briefly review the 
literature on electrospinning, phase separation and self-assembly. 
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2.5.1. Phase Separation 
The phase separation method works by inducing the phase separation of a polymer solution 
into a polymer-rich and a poor polymer phase. It has been widely used for the fabrication of porous 
scaffolds for tissue engineering applications [274, 275]. In recent years, aliphatic polyesters have 
been used in this technique. Briefly, a polymer such as PLLA is dissolved in a suitable solvent and 
rapidly cooled to induce phase separation. Afterward, the solvent is exchanged with water, and the 
construct is subjected to freeze drying. Some of the variations in the process include altering the 
gelling temperature and changing the polymer concentration [276, 277]. Apart from aliphatic 
polyesters like PLLA and PLGA, this technique has also been extended to polyhydroxyalkanoate, 
CS, gelatin and also gelatin/apatite composites [278]. However, this process has still been limited 
to just a few polymers and also the difficulty of scaling up has restricted the usage of this technique 
[265, 277]. 
 
2.5.2. Self-assembly 
 Self-assembly is a bottom-up approach to nanofiber production that relies on weak 
noncovalent interactions to build nanofibers from smaller molecules [271]. The building blocks 
are either naturally occurring or designed specifically for the occasion [279].   
Peptide-amphiphiles (PAs) are one of the commonly used building blocks and have been in 
existence for over a decade now [280]. The chemical structure of PAs permits the initiation of an 
assembly with just an adjustment in the ion content of the PA solution [281]. While this approach 
can generate nanofibers of the smallest scale, the processing procedure is still challenging and is 
limited to a small set of polymers. Also, this process can only create short fibers that are only a 
few microns long [264]. 
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2.5.3. Electrospinning 
 Electrospinning is a cost-effective technique that exploits the principles of electrostatic 
forces to generate fibers that have diameters either in microns or the nano-scale. In a typical 
process, a polymer solution is extruded out of a syringe and aimed at a collector plate. A potential 
difference is applied between the needle and the collector plate which helps the polymer droplet 
overcome the surface tension and take the form of fibers with the solvent evaporating before it 
reaches the collector plate. Some of the factors that are commonly varied to produce fibers with 
the right diameter are polymer concentration, needle tip to collector plate difference, applied 
potential difference, the geometry of the collector plate and polymer flow rate [265, 267, 282-285]. 
A variety of polymers has been used for electrospinning. Some of the synthetic polymers include 
PCL, PLLA, polyurethane, copolymers of PEG and PCL [286- 290]. Additionally, composite 
fibers have also been produced with natural, synthetic polymers and bioceramic constituents [224, 
291]. Researchers have used electrospinning previously for the fabrication of scaffolds for bone 
tissue engineering (BTE). For example, PLA/HA composite membranes were fabricated, and 
osteoblast cell adhesion was evaluated to be much better than that of pure PLA [292, 293]. To 
combat the problem of inefficient dispersion of ceramic particles, Kim et al. (2006) investigated 
the influence of a surfactant [294]. Mei et al. (2007) fabricated membranes for guided tissue 
regeneration (GTR) using PLA, Multiwalled Carbon Nanotubes (MWNTs) and HA and reported 
enhanced adhesion and mechanical strength [295]. Schneider et al. (2008) fabricated PLGA/TCP 
nanocomposite fibers and concluded that the membranes have a bright future in the regeneration 
of bone defects [296]. Recently, a layer by layer approach was used to fabricate PCL/CaCO3 
membranes [117]. Authors have also reported the difficulty experienced during the electrospinning 
of pure natural polymers and have often overcome this problem by adding synthetic polymers for 
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easier processing [297]. Yang et al. (2008) fabricated CS/polyvinyl alcohol (PVA) with HA 
biocomposite nano-scaffolds using electrospinning and concluded that the increase in HA content 
above 5% decreased the ultimate tensile strength and strain in failure. The scaffold’s capability to 
enhance cell adhesion was also reported [298]. Zhang et al. (2008) fabricated HA/CS nanofibers 
and highlighted the great potential of using these fibers for BTE applications [299]. Badami et al. 
(2006) made PDLLA, PLLA, PEG-PDLLA and PEG-PLLA nanofibers to evaluate the influence 
of surface topography on the cell morphology and cell proliferation [300]. Hu et al. (2013) 
concluded that electrospinning with dip coating is a possible technology for producing membranes 
for GBR and GTR [301].  
 
2.6. Summary of Literature 
 This literature review section is aimed to provide readers with a summary of the work 
done in the field of BTE focusing mainly on the regeneration of bone tissues. Key takeaways from 
the literature review can be summarized as follows (1) The design and fabrication of barrier 
membranes is crucial role in the success for GBR; (2) Composite materials have the potential to 
be the best option for barrier membranes; (3) Homogeneous dispersion of bioceramic particles is 
a key factor in electrospinning; (4) Cryomilling can be a cheaper and efficient alternative to 
traditional blending techniques. 
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CHAPTER III 
PRELIMINARY WORK 
Before the investigation of the primary hypothesis, pilot studies were conducted to 
understand the processing of polymer-ceramic composites. Two different processing techniques, 
electrospinning, and compression molding were initially pursued for the fabrication of GBR 
membranes. However, in the end, observations from the pilot studies, inferences from literature, 
and preliminary results from the In vitro studies had a significant influence on the way the 
experiments were finally designed. This section provides a brief summary of the various 
observations that were made during the pilot studies, and it also presents the logical reasoning for 
the modifications made in the experimental design. 
 
3.1. Design and Fabrication of Biocomposites 
3.1.1. Initial Composite Design 
A detailed literature review clearly revealed that the ideal material for the manufacture of 
barrier membranes had to be a blend of different materials [18]. In other words, the choice to 
generate composites for scaffolds was straight-forward. However, the constituents of the 
composites had to be chosen with care. To regenerate the alveolar bone which is an organic-
inorganic composite, it would be ideal for the scaffold to be made of both these components. PLA 
was chosen to be the first polymer representative based on its previous success in regenerative 
applications [183, 184]. CS was an obvious choice to be the natural polymer-agent because of its 
superiority to collagen. Some of the beneficial properties that CS offers include improved 
biocompatibility, enhanced cell adhesion, the ability to support osteoblast proliferation, minimal 
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immune response, low cost and also antimicrobial properties [43-45, 145, 146, 150, 151]. As 
mentioned in section 2.3.4, the addition of bioactive ceramics has shown to improve the 
regenerative capability of barrier membranes. The usage of TCP in the fabrication of membranes 
for GBR is well-documented and has been met with considerable success [219-221]. So, TCP was 
chosen to be the bioceramic in the blend. Table 1 shows the different combinations in which the 
materials were generated in the pilot study. The intention behind the design of composites was to 
evaluate various combinations to identify suitable blends for scaffold fabrication. The 
combinations A0*, A1*, A2* and A3* were designed to understand the interaction between PLA 
and TCP without CS. The samples B0* through C3* were designed to study the interaction of all 
the three materials. Samples B0*-B3* had a relatively higher percentage of PLA in the polymer 
matrix while samples C0*-C3* had a greater percentage of CS. Finally, the samples D0*-D3* were 
designed to understand the interaction of CS and TCP in the absence of the binder material, PLA. 
In this study, anything more than 20% of TCP in the polymer matrix was considered to be high as 
previous studies have reported agglomeration of TCP particles at such percentages [48].  
 Later, electrospinning and compression molding were used to fabricate scaffolds with the 
biocomposites prepared by cryomilling.  
               Table 1. Material compositions used for the pilot study 
Sample PLA/CS (Polymer Matrix) TCP/Matrix 
A0* 100/0 0/100 
A1* 100/0 10/90 
A2* 100/0 20/80 
A3* 100/0 30/70 
B0* 70/30 0/100 
B1* 70/30 10/90 
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      Table 1 continued 
Sample PLA/CS (Polymer Matrix) TCP/Matrix 
B2* 70/30 20/80 
B3* 70/30 30/70 
C0* 30/70 0/100 
C1* 30/70 10/90 
C2* 30/70 20/80 
C3* 30/70 30/70 
D0* 0/100 0/100 
D1* 0/100 10/90 
D2* 0/100 20/80 
D3* 0/100 30/70 
 
3.1.2. Cryomilling 
Once the material compositions were finalized, the literature was reviewed to identify the 
ideal blending technique for the fabrication of biocomposites. The literature review revealed the 
advantages of cryomilling in biocomposite fabrication [239]. Some of the benefits of using 
cryomilling include use of reduced energy, homogeneous dispersion even at higher loading 
percentages of ceramic particles and the added benefit of being a solventless process [48]. Also, 
researchers from Interdisciplinary Manufacturing Engineering and Design Laboratory (iMED), 
Iowa State University (ISU), have tasted considerable success in fabricating polymer composites 
using cryomilling [250, 252, 253]. The second hurdle was to identify the process parameters to be 
employed in the cryomilling process. Based on observations made by Lim et al. (2013) and 
observations from trial experiments run at iMED, the total cryomilling time was chosen to be  
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20 mins [48]. The other process parameters such as precool time, cooling time, cycles per second 
(cps) and number of cycles were chosen based on the manufacturer’s prescription. 
 
3.2. Production of Membranes for Guided Bone Regeneration 
After the blending and fabrication of biocomposites by cryomilling, electrospinning and 
compression molding were explored for the production of GBR membranes. The inferences from 
the experiments involving these techniques are provided in the following sections. 
 
3.2.1. Electrospinning 
As nanofibrous scaffolds have had great success with GBR, electrospinning was an 
appropriate choice for the fabrication of membranes [292-296]. This study being the first to 
produce a three-material biocomposite powder blend for the fabrication of GBR membranes, only 
made it harder to identify the appropriate process parameters to ensure repeated fabrication of 
fibrous membranes. Moreover, the different material properties of the various constituents of the 
biocomposites was an added challenge. First attempts that were made to fabricate nanofibers used 
chloroform and dimethylformamide (DMF) (3:1 v/v) as the solvents to dissolve the composite 
blends based on the experiments reported by McCullen et al. for PLA/TCP composites [302]. 
Another solvent combination that was tried was dichloromethane (DCM) and DMF (7/3 v/v) [301]. 
However, both the solvent combinations mentioned above did not yield expected results with 
combinations that contained a high percentage of CS (C0*-D3*). This was attributed to CS’s ionic 
character in dissolved state and three-dimensional networks of strong hydrogen bonds [47]. Also, 
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the composites with TCP posed a challenge because of their rheological properties which caused 
aggregation at higher loading percentages (A3*, B3*, C3*, D3*). 
At the end of the pilot study, it was concluded that the high ceramic content in some cases 
and presence of CS in other cases were responsible for the failure of DCM, DMF, and chloroform 
in being the common solvent. It was also inferred that CS was insoluble at neutral and alkaline pH 
but was soluble in acidic media. Thus, trifluoroacetic acid (TFA) was chosen as the co-solvent for 
the purpose of electrospinning. 
 
3.2.2. Compression Molding 
Compression molding was used to fabricate bone tissue 
scaffolds using an entirely solvent-free approach [303]. Briefly, 
the aluminum mold was preheated to a temperature of 195℉, and 
a pressure of 5000 psi was applied for 15 mins once the 
composite material was placed inside. Fig. 5 is an image of the 
compression molded film that was fabricated using this 
protocol. However, the In vitro studies with MG63 cells did not yield expected reasons. Some of 
the scaffolds (A3*, B3*, C3*, D3*) crumbled when placed in the cell culture medium because of 
their relatively higher TCP content. Moreover, all the scaffolds lacked porosity and were not able 
to assist in guiding and promoting cell proliferation.  
At the end of the In vitro study, it was inferred that a porous and interconnected scaffold 
architecture along with reduced TCP content would create an environment that would facilitate 
proliferation and migration of the cells. 
 
Fig. 5. A3* compression molded scaffold  
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3.3. Modified Experimental Design 
3.3.1. Electrospinning 
The observations from work published by Tanase et al. (2014) were used to redesign the 
composites [185]. The biocomposites that were generated 
in this study are as follows:  A0: 100% PLA; A1: 70% 
PLA, 30%CS; A2: 68% PLA, 30%CS, 2% TCP; A3: 
66%PLA, 30%CS, 4%TCP. TFA was used as the co-
solvent for the purpose of electrospinning. In a 
typical process, 18-20 w/v% of the composite powder 
was added to 5 ml of TFA, and the solution was stirred using 
a magnetic stirrer at 25 ℃ for at least 24 h for better 
dispersion and homogenization of the ceramic particles. The 
solution was then transferred to a 5 ml syringe with an 18G 
needle. A stationary copper plate covered with aluminum foil 
was used as the collector plate. The needle tip to collector distance was set to 13 cm, and the 
potential difference was adjusted between 15-17.5 kV as needed with a constant solution flow rate 
of 0.05 ml min-1. Fig. 6 is a photograph of a barrier membrane that was prepared using 
electrospinning during this study. Fig. 7 is a micrograph of an electrospun membrane generated 
with A3. 
 
3.3.2. Compression Molding 
The compression molding fabrication protocol was designed based on previously published 
work on BTE scaffolds [185, 304]. Compression molding was used to fabricate scaffolds, which 
Fig. 6. Electrospun PLA/CS/TCP barrier membrane 
Fig. 7. Morphology of A3 membrane 
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were later immersed in water for porogen leaching. Firstly, the composite powder and sodium 
chloride (NaCl) particles were mixed using a magnetic stirrer. The 
mass ratio of sodium chloride to composite powder was chosen to 
be 1.6:1 (w/w). After 30 mins of mixing, the mixture was 
transferred into a stainless-steel mold with cylindrical cavities  
(d = 9 mm; h = 13 mm). The compression molding process was 
carried out using a hydraulic press. The mold was preheated to 
175℃, and the molding process was carried out with a pre-pressing step  
of 3 mins at 50 atm and a pressing step of 2 mins at 150 atm. The fabricated scaffolds were then 
porogen leached in distilled water for 24 h and dried in a programmable vacuum oven overnight. 
Fig. 8 shows a micrograph focused on the cross-section of the generated scaffolds. Fig. 9 indicates 
the dimensions and surface texture of the scaffolds that were generated. However, the In vitro 
studies once again revealed that the scaffolds underwent uncontrolled swelling in the culture 
medium and crumbled. So, the fabrication and the results of the 
compression molded scaffolds were omitted from the paper that has 
been submitted for peer-reviewed publication. Fig. 10 shows an 
image of the crumbled scaffolds in the culture medium. It was later 
hypothesized that the addition of a binder like polyethylene oxide 
(PEO) could improve the overall structural integrity of the scaffolds 
[305].   
 
 
Fig. 8. Porous scaffold architecture (A2) 
Fig. 9. A compression molded scaffold 
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Fig. 10. Crumbled scaffolds in culture medium 
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CHAPTER IV 
Fabrication and Evaluation of Poly (lactic acid)/Chitosan/Tricalcium Phosphate 
Biocomposites for Guided Bone Regeneration 
Manuscript to be submitted to Materials Science and Engineering C 
Srikanthan Ramesh1a, Lisa Lungaro2a, Dimitrios Tsikritsis2, Iris Rivero1*, Alistair Elfick2 
4.1. Abstract 
This study aims to validate the preparation approach of biodegradable polymer-bioactive 
ceramic composites, and evaluate their suitability for guided bone regeneration (GBR). GBR is a 
dental surgical procedure that uses barrier membranes to guide the growth of new bone tissues. 
Resorbable membranes eliminate the need for second surgeries that patients with non-resorbable 
membranes need. Cryomilling, a solid-state blending process, facilitates bulk fabrication by 
eliminating difficulties such as high viscosity, insolubility and long processing times. 
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It is a cost-effective technique to generate particles with high surface area to volume ratio, 
which provide a larger area for biological activity. X-Ray diffraction and differential scanning 
calorimetry were used to characterize the molecular structures and glass-transition temperatures 
of the powder composites prepared by cryomilling. Scanning electron microscopy was used to 
study the morphology of the membranes generated by electrospinning. In vitro studies were 
performed with MG63 cells to quantify the blend’s capability to encourage cell proliferation. 
Coherent anti-Stokes Raman spectroscopy and fluorescence microscopy were used to analyze cell 
proliferation qualitatively. A 21-day in vitro degradation study was performed on the electrospun 
membranes and analyzed using Raman spectroscopy. CellTiter-Blue® cell viability assay 
performed on cells grown on membranes revealed that cells are viable and metabolically active 
both at 3 and 7 days from cell seeding, indicating the suitability of the biocomposites for GBR. 
Key words: PLA/CS/TCP, Biocomposites, Guided Bone Regeneration, Cryomilling, 
Electrospinning 
4.2. Introduction 
In the recent years, the increasing interest in developing dental procedures for bone 
regeneration has been a consequence of the growing number of patients in need of such 
interventions. Based on the data from the 2009 and 2010 National Health and Nutrition 
Examination Survey (NHANES), Eke et al. reported that 64.7 million adults in the United States 
(U.S.) suffer from periodontitis with varying levels of severity [1]. Periodontitis is a dental disease 
that is characterized by the destruction of the connective tissue and dental bone support due to an 
inflammatory response to the infection caused by the presence and activity of bacteria [2, 3]. 
Guided Bone Regeneration (GBR), when used, has been able to treat various bone defects caused 
by periodontitis [4-6]. In principle, GBR uses barrier membranes to prevent the entry and 
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proliferation of non-osteogenic cells in the defect sites by selectively permitting the growth of 
osteogenic cells [7]. Therefore, the success of the procedure, amongst other factors, is also largely 
dependent on the design and performance of the barrier membrane. A suitable barrier membrane 
is expected to be biocompatible, mechanically stable and flexible during the time of implantation 
[8]. It has been suggested that a barrier membrane used in GBR should support the formation and 
maturation of the new bone for at least six weeks [9-10]. Expanded polytetrafluoroethylene (e-
PTFE) has by far been the most preferred material for the fabrication of non-resorbable membranes 
[11, 12]. However, it has been suggested that the use of stiff non-resorbable membranes may result 
in wound dehiscence exposing the operated site to infection [13]. Resorbable membranes have 
acted as alternatives by eliminating the need for removal surgeries [14]. Natural polymers such as 
chitosan (CS) [15-17], collagen [18] and synthetic polymers like poly (lactic acid) (PLA) [19-21], 
poly (𝜀𝜀-caprolactone) (PCL) [22-24], poly (lactic-co-glycolic acid) (PLGA) [25-27] have been 
used individually or in blends for the fabrication of barrier membranes. The addition of bioactive 
ceramics such as hydroxyapatite (HA) [28] and tricalcium phosphate (TCP) [29] has also been 
proven to improve the mechanical and biological properties of barrier membranes. Composite 
materials have allowed the fabrication of tailor-made barrier membranes that exhibit positive 
synergistic effects [30]. The compatibilization strategies for the fabrication of polymer blends and 
polymer-ceramic composites have traditionally involved the use of solvents and high temperatures 
[31]. Unfortunately, these techniques have several limitation such as: a) non-homogeneous mixing 
[32], b) denaturing of biomolecules [33], and c) increased operation costs due to slow reaction 
kinetics [34]. These drawbacks necessitate the development and use of safe, low-temperature, 
solid-state techniques for the processing of biocomposites. 
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This study intends to validate the fabrication approach of novel biodegradable polymer-
bioactive ceramic barrier membranes for use in GBR. A low-temperature, solid-state, blending 
technique called cryomilling was employed to generate polymer-ceramic biocomposites made of 
PLA, CS, and TCP. As mentioned previously, PLA-based membranes have produced considerable 
success when used for GBR. CS, apart from being resorbable and biocompatible, was also chosen 
for its antimicrobial properties [35]. Moreover, the role of CS in cell adhesion, proliferation, and 
osteoblast differentiation has been well documented [36-38]. TCP was used as a synthetic bone 
substitute material to induce the regeneration of bone tissue [39-41]. Even though these materials 
have been previously used in the fabrication of scaffolds for GBR, the potential of a biocomposite 
with these materials remains unexplored. 
In this study, electrospinning was employed to generate barrier membranes due to its 
previous success in bone tissue engineering (BTE) applications [42-44]. RAW 264.7 murine 
macrophages were used to evaluate the cytocompatibility of the generated biocomposites and 
investigated by CellTiter-Blue® (CTB®) cell viability assay. Further, the electrospun membranes 
were evaluated for their capability to support the growth of MG63 cells using CTB® cell viability 
assay. A live/dead viability assay was also conducted, and the fibers were qualitatively analyzed 
using coherent anti-Stokes Raman Spectroscopy (CARS) and fluorescence microscopy. Also, a 
21-day In vitro degradation studied was performed and analyzed using Raman spectroscopy. 
 
4.3. Materials and Methods 
4.3.1. Fabrication of PLA/CS/TCP Biocomposites 
PLA (Purasorb PL 10; Corbion Purac), CS (448877-50G, Medium Mw; Sigma-Aldrich), 
TCP (C5267-100G, 34.0-40.0% Ca basis; Sigma-Aldrich) were cryomilled to generate  
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polymer-ceramic powder composites. Compositions of the blends prepared are as follows: A0: 
100% PLA; A1: 70% PLA, 30% CS; A2: 68% PLA, 30% CS, 2% TCP; A3: 66% PLA, 30% CS, 
4% TCP. Briefly, exact quantities of each material were transferred into a polycarbonate vial with 
stainless-steel impactors and end plugs. The vial was then loaded into the freezer mill (6870; 
SPEX, Metuchen, NJ, USA) which was maintained at a temperature of -196 ℃ using liquid 
nitrogen. Each composition was cryomilled for 20 mins in 4 cycles. A cooling time of 1 min was 
allowed between successive cycles and a precool time of 4 mins was utilized to ensure 
homogeneity in temperature at the time of milling. A total sample weight of 5 g was used for every 
run. The samples were stored in a silica-filled desiccator for at least 48 h at room temperature 
before further processing. 
 
4.3.2. Fabrication of PLA/CS/TCP Biocomposite Membranes 
Electrospinning was employed to generate fibrous membranes using the generated 
biocomposites. Trifluoroacetic acid (TFA) (O4902-100; Fisher Scientific) was used as the 
common solvent. In a typical process, 18-20 w/v% of the cryomilled powder was added to 5 ml of 
TFA, and the solution was stirred using a magnetic stirrer at 25 ℃ for at least 24 h to ensure 
homogeneous dispersion of the bioceramic particles. The solution was then transferred to a 5 ml 
syringe with an 18G PrecisionGlide needle (Becton-Dickinson, Franklin Lakes, NJ, USA). A 
stationary copper plate covered with aluminum foil was used as the collector plate. The needle tip 
to collector distance was set to 13 cms, and the potential difference was adjusted between  
15-17.5 kV as needed with a constant solution flow rate of 0.05 ml min-1. All the electrospun 
membranes were kept at 40 ℃ in a vacuum oven for 24 h before the further investigation was 
performed. 
40 
 
 
4.3.3. Scanning Electron Microscopy 
The morphology of the samples was analyzed using a JEOL JCM-6000Plus NeoScope 
Benchtop scanning electron microscope (SEM) (JEOL, Peabody, MA, USA). Accelerating 
voltages of 10-15 kV were used depending on the requirement. The fiber diameter was measured 
using JCM-6000 software version 1.1. The mean diameters of the barrier membranes were 
calculated using thirty measurements from three independent samples. All diameter values have 
been reported as mean ± standard deviation (SD). 
 
4.3.4. X-Ray Diffraction Analysis 
X-Ray Diffraction (XRD) analysis was performed to confirm the occurrence of a 
homogenous composite blend. The biocomposites were analyzed using the Rigaku Miniflex 600 
XRD analysis unit (Tokyo, Japan). The voltage and current applied were 30 kV and 15 mA 
respectively. A scintillator counter (SC-70) was used as the detector. The scan ranged from 3 to 
80 degrees with steps of 0.02 degrees. PDXL (version 2.1.3.4.) was used to analyze the data. 
 
4.3.5. Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) (Phoenix, NETZSCH Instruments, Burlington, 
MA, USA) was used for thermal characterization of the generated biocomposite powders. In a 
typical measurement process, 8 mg of the sample was analyzed using aluminum pans and argon 
purge gas. An empty aluminum crucible was used as the reference. In order to avoid the 
degradation of CS, the method of Sakurai et al. was used with modifications [45]. Suyatma et al. 
have reported the success of this method for the thermal characterization of PLA/CS biodegradable 
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films [46]. The samples were quenched to at -10 K min-1 to -30 ℃ before being heated to 190 ℃ 
at the same rate. The samples were held at 190 ℃ for 1 min before being cooled down to -30 ℃. 
The samples were then held at -30 ℃ for 3 mins before the second heating cycle in which the 
samples were heated up to 250 ℃. The second heating scan was used to identify the glass transition 
and melting temperatures of the cryomilled blends. Proteus Thermal Analysis version 6.1.0 was 
used for the analysis. 
 
4.3.6. Powder Preparation for Cell Cytotoxicity Study 
Powders A0, A1, A2 and A3 were weighed on a precision scale and were suspended in a 
standard Dulbecco’s Modified Eagle’s Medium (DMEM) at a concentration of 0.84% w/v (0.05 g 
powder in 6 ml of standard medium), creating respectively StockA0, StockA1, StockA2, and 
StockA3 medium. Each stock medium was then transferred into a Pyrex bottle and autoclaved at 
121 ℃ for 15 mins. Stock media were cooled to room temperature, then each of them was diluted 
to a final concentration of 3 µl/ml, 10 µl/ml, 30 µl/ml and 50 µl/ml using the standard medium. 
The new solutions were named CompA0, CompA1, CompA2 and CompA3 medium. 
 
4.3.7. Cell Cytotoxicity Study using RAW 264.7 Murine Macrophages 
 RAW 264.7 murine macrophage cell line was used to test the cytocompatibility of 
CompA0, CompA1, CompA2 and CompA3 medium, in different concentration as explained in 
section 4.3.6. Cytotoxicity was tested by treating macrophages with powders suspensions in 
standard medium, as performed by Varmette et al. (2008) [47]. The cells, at passage 12, were 
cultivated in standard DMEM medium (Sigma-Aldrich, Irvine, UK) supplemented with 10% Fetal 
42 
 
 
Bovine Serum (FBS) (Invitrogen, Paisley, UK) and 1% penicillin/streptomycin  
(100U/ml/100 µg/ml, Invitrogen, Paisley, UK). When confluent, cells were trypsinized, counted 
and subsequently seeded into 96-well plate at the concentration of 3x104 cells/well in a volume of 
100 µl of the medium. Cells were then incubated for 24 hours at 37 °C, 5% CO2, and subsequently 
exposed to CompA0, CompA1, CompA2 and CompA3 and added to cell culture at final 
concentrations of 3 µl/ml, 10 µl/ml, 30 µl/ml and 50 µl/ml in 100 µl of medium/well. Cells were 
incubated for 24 h at 37 °C, 5% CO2 and at the end of the incubation time, cells were imaged using 
bright microscopy (BF). Then, CompA0, CompA1, CompA2 and CompA3 media were replaced 
with fresh, standard medium and cells were incubated for further 24 h and 48 h, before proceeding 
with the CTB® cell viability assay. 
 
4.3.8. CellTiter-Blue® Cell Viability Assay on RAW 264.7 Murine Macrophages 
Cell viability was investigated using CTB® cell viability assay (Promega, Southampton, 
UK) after 24 and 48 h from the end of the treatment with Comp A0, A1, A2 and A3 media. Briefly, 
20 µl/well of the reagent was added to cells grown in a 96-wells plate, according to the 
manufacturer's protocol. Then, cells were incubated in an incubator at 37 °C, 5% CO2 for 3 h. At 
the end of the incubation time, the supernatant of each well was transferred to a fresh 96 wells 
black plate, glass bottom, and fluorescence was measured with a microplate reader (Modulus™ II 
Microplate Multimode Reader, Turner Biosystems, Sunnyvale, California, USA) at 560/690 nm. 
Cells grown in the standard medium were used as controls and samples were investigated in 
triplicates. All data are expressed as mean values along with minimun and maximum values. At 
the end of the incubation time with CompA0, A1, A2 and A3 media, cell morphology was 
evaluated using BF microscopy (Leica Microsystem, Milton Keynes, UK), at 200x magnification. 
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4.3.9. MG63 Cell Seeding on Electrospun Membranes 
MG63 Human Osteosarcoma cell line was cultivated in standard DMEM medium (Sigma-
Aldrich, Irvine, UK) supplemented with 10% FBS (Invitrogen, Paisley, UK) and 1% 
penicillin/streptomycin (100U/ml/100 µg/ml, Invitrogen, Paisley, UK). When confluent, cells 
were trypsinized, counted, suspended into 30 µl of medium and subsequently seeded into scaffolds 
at the concentration of 7.5x104 MG63 cells/scaffold. Before cells seeding, scaffolds were placed 
one per well in a sterile 48 wells plate, UV irradiated for 15 mins and pre-soaked into standard cell 
medium for 10 mins. At the end of the soaking time, the medium was removed, and cells were 
seeded. Cell attachment was favored by incubating scaffolds at 37 °C, 5% CO2 for 15 mins and 
then 500 µl of standard medium were gently added to each scaffold. The day after, scaffolds were 
gently transferred to a fresh 48 wells plate, to avoid any contribution of cells that have not grown 
directly on the scaffolds, as done by Tampeiri et al. (2014) [48]. The medium was changed every 
2 days. MG63 cells viability and proliferation was investigated after 3 and 7 days. All cell 
manipulation procedures were conducted in a sterile laminar flow hood. 
 
4.3.10. Cell Viability Investigation by Fluorescence Microscopy 
Cell viability was qualitatively investigated using LIVE/DEAD Viability/Cytotoxicity Kit 
for mammalian cells (Invitrogen, Paisley, UK), as suggested by the manufacturer's protocol. 
Briefly, 7.5x104 MG63 cells were seeded into each electrospun scaffold as previously described 
and then incubated at 37 °C, 5% CO2 for 3 and 7 days respectively. At the end of the incubation 
period, the medium was removed, and scaffolds were incubated with Calcein acetoxymethyl 
(Calcein-AM) 2 µM plus Ethidium homodimer-1(EthD-1) 4 µM for 15 mins at 37 °C, 5% CO2, 
in the dark. At the end of the incubation time, each scaffold was gently washed with 1 ml of PBS 
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1X. Fluorescent dyes were excited and imaged using two-photon emission fluorescence (TPEF), 
while scaffolds fibers were depicted using CARS. The laser used is a HighQ picotrain laser unit 
providing a 1064 nm and a 532 nm beam [49]. The OPO beam was set at 813 nm.  The Filters used 
to read the green fluorescent were Semrock 515/42 combined with a 535/40 band-pass filter. For 
the Red fluorescent marker, the filters used were 609/54 and 640/14 band-pass filters while for the  
non-resonant CARS, the 660/13 band-pass filter was used. 
 
4.3.11. CellTiter-Blue® Cell Viability Assay on MG63  
MG63 cell viability was investigated using CTB® cell viability assay (Promega, 
Southampton, UK), respectively after 3 and 7 days from cells seeding into scaffolds. Cell viability 
was determined by using the indicator dye Resazurin, which is reduced into highly fluorescent 
Resorufin by viable cells, while non-viable cells do not to perform the reaction and so no 
fluorescence is registered. Briefly, 7.5x104 MG63 cells were suspended into 500 µl of the medium 
and seeded into each electrospun scaffold as previously described, in a 48 wells plate. Scaffolds 
were then incubated at 37 °C, 5% CO2 for 3 and 7 days respectively. At the end of the incubation 
period, 100 µl of CellTiter-Blue solution were added to scaffolds, which were incubated in an 
incubator at 37 °C, 5% CO2 for 3 h. At the end of the incubation time, the supernatants of each 
well together with the scaffolds were transferred into a fresh micro vial which was centrifuged at 
1,000 rpm for a minute. The supernatants were taken and put into a fresh micro vial and mixed by 
vortex. Then, 100 µl of the supernatants were transferred into a dark glass bottom plate, and 
fluorescence was measured with a microplate reader (Modulus™ II Microplate Multimode Reader, 
Turner Biosystems, Sunnyvale, California, USA) at 560/690 nm. Cells grown in standard medium 
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were used as controls and samples were investigated in triplicate. All data are expressed as mean 
values along with minimun and maximum values. 
 
4.3.12. In vitro Degradation of Electrospun Membranes 
Electrospun membranes of A0, A1, A2, and A3 were cut into 4 different pieces and UV 
irradiated for 15 mins for sterilization. Then, in order to study material degradation, samples were 
incubated in distilled, purified, sterile water at 37 °C, 5% CO2 for 7, 14 and 21 days. At each time 
point, samples were investigated using Raman spectroscopy. The results are the products of 20 
different spectra from 20 different locations on each sample. 
 
4.3.13. Statistical Analysis 
Results of the CTB® cell viability assay were analyzed using PRISM® version 7.0 
(GraphPad Software, San Diego, CA, USA) with 95% confidence intervals (CI) of the difference. 
Shapiro-Wilk W test was used to check the normality of the data because of its higher power for 
small sample size when compared to the other normality tests [50]. Two-way ANOVA was 
performed to examine the influence of two different categorical independent variables on a single 
dependent variable. Post-hoc Tukey Honestly Significant Difference (HSD) test was utilized to 
perform multiple pairwise comparisons when the two-way ANOVA confirmed statistical 
significance. All the analyses were conducted with the designated Type I error rate of 0.05 [51]. 
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4.4. Results and Discussion 
4.4.1. Morphology of Cryomilled Composites 
As previously mentioned in the introduction, biocomposites serve as a convenient option 
to fabricate barrier membranes that could elicit desirable biological responses from the human 
body. In this study, cryomilling, a low-temperature solid-state technique was used for the 
generation of polymer-polymer and polymer-ceramic powder blends. Cryomilling has repeatedly 
been used in the past to develop homogeneous blends of immiscible polymers [52]. It has been 
shown to produce finer grain structures in relatively shorter processing times [53]. Recently, Lim 
et al. employed cryomilling for the fabrication of polycaprolactone/TCP composites and reported 
that homogeneous dispersion could be attained even at high loading percentages of TCP [54]. 
Apart from eliminating the need for solvents and high temperatures, cryomilling also requires 
lesser energy to induce a material fracture as the entire process as the milling is done below the 
glass transition temperature of the polymers. Fig. 11 shows a micrograph of a cryomilled polymer–
ceramic blend (A3) that was generated in this study. The composite powder was found to be made 
up of particles with sharp edges, and the particle size of the composite blend was visibly smaller 
than the particle size of the materials before cryomilling. The agglomeration observed, is because 
of the presence of electrostatic, steric and van der Waals forces between the particles [55-57]. 
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Fig. 11. SEM image of PLA/CS/TCP cryomilled composite particle (A3) 
 
4.4.2. X-Ray Diffraction Analysis of Cryomilled Powders 
XRD was utilized to confirm the occurrence of a homogeneous blend PLA, CS, and TCP. 
Fig. 12 shows the XRD profiles for as-received CS, and TCP along with the profiles for the 
composite blends prepared by cryomilling. The first characteristic diffraction peak for PLA (A0) 
occurs at a 2θ value of 16.38° and the second major peak can be seen at a 2θ value of 18.76°. For 
pure CS, the only evident characteristic diffraction peak occurs at a 2θ value of 19.48°. TCP has 
two distinct diffraction peaks close to a 2θ value of 30°. The XRD profiles of A1, A2 and, A3 
showcase PLA peaks at 2θ values of 16.38° and 18.76° indicating the presence of PLA. Also, the 
presence of CS can be confirmed by observing the profiles of the composite materials close to a 
2θ value of 19.48°. It can clearly be observed that the profiles of the composite materials show 
relatively higher intensities at those points indicating the presence of CS. Similarly, the composite 
blends consisting of TCP particles have profiles with relatively higher intensities at 2θ values close 
to 30° when compared to the blends without the ceramic component. In conclusion, it can be said 
that the cryomilling process generated a homogeneous blend of materials as the composite blends 
have a unique profile that is different from the profile of the individual constituent materials. 
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Fig. 12. XRD profiles of composite blends along with their individual components 
 
4.4.3. Differential Scanning Calorimetry Analysis of Cryomilled Composites 
DSC was used for thermal characterization of the biopolymer-bioceramic powder blends 
that were prepared by cryomilling. The DSC profile of PLA (A0) (Fig. 13) clearly resembles a 
typical profile of a semi-crystalline polymer. The glass transition occurs at a temperature of 59 °C, 
and a cold crystallization can be seen as an exothermic peak beginning at around 150 ℃. The 
melting point of pure PLA was identified to be 179.5 °C which was close to the value provided by 
the manufacturer. It was observed that the addition of CS and TCP increased the glass transition 
temperature of PLA (Table 2). Based on observations made by Tanase et al. (2014), it was 
hypothesized that the movement of PLA chains was hindered by the addition of CS and TCP [58]. 
It was also identified that the melting temperature of the membranes decreased with the addition 
of TCP particles indicating the development of less crystalline materials. It was reasoned that the 
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TCP particles acted as obstacles and prevented the growth of crystal structures [59]. Table 1 also 
shows the melting point data obtained from the second heating scan. 
 
     Fig. 13. DSC second heating scans of the cryomilled composites 
 
Table 2. DSC glass transition and melting data 
Material Glass Transition (°C) Melting Point (°C) 
A0 59 179.5 
A1 60.1 178 
A2 63.3 175.4 
A3 63.9 177.2 
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4.4.4. Morphology of Electrospun Barrier Membranes 
In this study, fibrous membranes were generated using electrospinning. Bhardwaj et al. 
(2010) describe electrospinning as “a technique that uses electrostatic forces to generate thin fibers 
from polymer solutions” [60]. In the past, researchers have had tremendous success is fabricating 
polymeric fibrous scaffolds for tissue engineering applications [61]. The processing conditions in 
electrospinning, including viscosity, molecular weight of polymer, applied voltage, needle tip-
collector plate distance, solution flow rate, have been shown to have a significant effect on the 
morphology of the fibers generated [62]. The observations from the pilot studies revealed the 
inability of solvents such as dichloromethane (DCM), dimethylformamide (DMF), and chloroform 
to act as the common solvent. This phenomenon was attributed to their ionic character in dissolved 
state and three-dimensional networks of strong hydrogen bonds [63]. It was also observed that CS 
was insoluble at neutral and alkaline pH but dissolved in acidic media [64]. 
Based on observations made during the pilot study, 18-20 w/v% was identified to be the 
optimum concentration for electrospinning A0, A1, A2, and A3. Fig. 14 shows SEM images of the 
fibers that were generated from each blend along with their corresponding diameter distribution 
profiles. While comparing the fiber diameters of pure A0 and A1, it was obvious that the 
introduction of CS resulted in the generation of relatively thicker fibers. This was found to be in 
agreement the observations made by Xu at al. (2009) [65]. Hence, it was concluded that the 
increase in PLA content resulted in the disappearance of beads and resulted in a finer fiber 
morphology. It was also noted that as the content of TCP particles increased in the composite 
matrix, the fiber diameter shifted to a higher range indicating that the TCP particles were 
responsible for this increase. Yang et al. (2008) have reported similar observations while 
electrospinning PVA/CS with HA fillers [66].  
AO 
51 
 
 
 
Fig. 14. SEM images and diameter distributions of electrospun barrier membranes 
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4.4.5. Cell Viability Assay on RAW 264.7 Murine Macrophages 
The cytotoxicity of the composite cryomilled powders blend A0, A1, A2 and A3 was tested 
on murine macrophage RAW 264.7 cell line, as described in the Materials and Methods section. 
Cell viability was determined by CTB® assay (Fig. 15 (a, b)). Results indicate that 24 h after 
returning in standard medium cultivation, cell viability is statistically reduced respect to the control 
for all the concentrations tested. However, 48 h after returning in standard medium cultivation, the 
gap in cell viability between cells cultured with different cryomilled powders and controls is 
reduced and no statistical differences was notice between controls and cells cultured with powders. 
After 24 h of incubation with composite cryomilled powders blend A0, A1, A2 and A3, the cell 
morphology was investigated using BF microscopy (Fig. 16 (a – e)). The investigation revealed 
that powders particles, when in the medium, tended to agglomerate creating bigger structures, and 
macrophages grew around or all over them. There were no obvious differences in the morphology 
between macrophages cultured with composite cryomilled powders and the controls. 
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Fig. 15. CTB® assay performed on RAW 264.7 cell line incubated with composite cryomilled powders blend A0, 
A1, A2 and A3, at different concentrations, after 24 h (a) and 48 h (b) from returning in standard medium 
conditions. Results are indicated as mean with min. and max. values. 
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Fig. 16. BF microscopy of RAW 264.7 macrophages incubated for 24 hours with different composite cryomilled 
powders at concentrations a) 3 µl/ml, b) 10 µl/ml,  
c) 30 µl/ml, d) 50 µl/ml, e) control; Magnification = 200X; Scale bar = 20µm. 
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4.4.6. MG63 Cell Viability Investigation by Fluorescence Microscopy 
The viability of MG63 cells was qualitatively examined at day 3 and 7 from cell seeding 
into scaffolds by fluorescence in green, red and CARS microscopy. All the scaffolds show high 
cell viability and low number of dead cells, as shown in Fig. 17, where living cells are stained in 
green and dead cells are stained in red. Cells were able to colonize the scaffolds, growing and 
dividing on them. Moreover, scaffolds A2, A3 and A3 appeared more suitable for cell attaching 
than scaffold A0, as indicated by the pictures which show a higher number of cells growing inside 
the scaffold fibers. Scaffolds A1 and A3, in particular, were noticed to have a good cell attachment 
along scaffold fibers. 
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Fig. 17. Fluorescence microscopy on MG63 cells seeded into electrospun scaffolds.  
Living cells are green, dead cells are red. Scaffolds fibers are depicted using CARS. Scale bar = 25 µm. 
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4.4.7. MG63 Cell Viability Investigation by CellTiter-Blue® Assay 
MG63 cell viability was evaluated also by CTB® assay, at day 3 and 7 from cell seeding 
into scaffolds (Fig. 18). The results confirm the observations from the fluorescence investigation, 
showing that cells are viable at both the time points investigated. Moreover, there is an increase of 
registered fluorescence intensity, corresponding to an increase of cell viability, at day 7 respect to 
day 3, showing that cells are able to integrate inside the scaffolds and to grow on them with the 
passing of days. No statistical difference in cell viability was noticed between scaffolds types at 
both the days investigated, indicating that all the scaffolds have a comparable performance. 
 
Fig. 18. CTB® assay performed on MG63 cells seeded into electrospun scaffolds, after 3 and 7 days from cell 
seeding. Results are indicated as mean with min. and max. values. 
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4.4.8. In vitro degradation study on electrospun membranes 
Fig. 19, 20, 21 show the Raman spectra for PLA, CS and TCP respectively. The spectra 
obtained from electrospun membranes were used to explain the degradation behavior of the 
biocomposites. The investigation revealed that A0, made of 100% PLA, showed a poor 
degradation through time (Fig. 22). The slow degradation of PLA was attributed to the presence 
of hydrophobic methyl groups [67]. Sample A1 shows a degradation at day 7 which is increased 
at day 14 and day 21, particularly in the region of 1400-1500 cm-1, where the expected degradation 
is shown (Fig. 23). Sample A2 shows an unusual degradation pattern that suggests that sample is 
more degraded at day 7 and 14 than at day 21. This could be due to sample flotation as seen in A0 
(Fig. 24). Sample A3 shows the expected degradation pattern, and it is more degraded at day 14 
and 21 than at day 7 (Fig. 25). It was concluded that the addition of CS favored the degradation of 
PLA by increasing the hydrophilicity of the membrane [68]. The accelerated degradation can also 
be explained by the fact that CS is a molecule that dissolves and degrades in acidic environments 
[69]. The accelerated degradation of A1 and A2 membrane showed confirmed the hypothesis that 
the TCP particles had reduced the crystallinity of pure PLA membranes. 
 
 
Fig. 19. Raman spectra of pure PLA  Fig. 20. Raman spectra for pure CS 
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Fig. 21. Raman spectra of pure TCP 
 
 
Fig. 22. Raman spectra of A0 electrospun membrane 
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Fig. 23. Raman spectra of A1 electrospun membrane 
 
 
Fig. 24. Raman spectra of A2 electrospun membrane 
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Fig. 25. Raman spectra of A3 electrospun membrane 
 
4.5. Conclusions 
Cytotoxicity test on powders used for scaffolds creation revealed a toxicity for 
macrophages, as their viability is reduced 24 h after returning in standard conditions after 
incubation with powders respect to the untreated controls. However, this effect could be due to the 
tendency of the powders to form large agglomerates when in suspension and not because of the 
toxicity of the materials used, as all the materials that have been utilized have known biocompatible 
properties [19-21] [35-38] [39-41]. When nanoparticles aggregate, cytotoxicity could arise from 
many factors such as particle charge, extent of aggregation and cell type used and it is difficult to 
define in a generic way which of them are predominant on macrophages cytotoxicity [70, 71]. 
However, after 48 h from returning in standard medium cultivation, viability of macrophages 
incubated with powders is comparable with the one of controls. This could be interpreted as a 
transient toxicity of powders, meaning that when powders are removed from cell medium, cells 
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recover their viability and proliferation activity. In addition to that, electrospun fibers scaffolds 
formed by these powders show a good biocompatibility and they appear suitable for osteoblast-
like cells adhesion and proliferation. MG63 cells show a good attachment to scaffolds fibers and 
cells growth increases with the passing of days. Also, the biocomposite membranes showed a 
better degradation behavior when compared to pure PLA membranes. 
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CHAPTER V 
GENERAL CONCLUSIONS 
5.1. Conclusions 
This study presented the fabrication and characterization of novel PLA/CS/TCP 
biocomposites. Further, electrospun barrier membranes were generated using these biocomposites, 
and their suitability for GBR was evaluated using RAW 264.7 murine macrophages and MG63 
cells. This chapter summarizes the conclusions that were drawn from this specific study and also 
validates some of the critical inferences from research works published on the topic of interest.  
 
5.1.1. Fabrication of PLA/CS/TCP Powder Composites 
 This study validated the use of a solid-state blending technique called cryomilling for the 
generation of powder composites made of PLA, CS, and TCP. As reported by Lim et al. (2014), a 
total milling time of 20 mins resulted in an obvious decrease in particle size of the constituent 
materials and the generation of homogeneous blends of PLA, CS, and TCP [48]. The occurrence 
of a homogeneous blend was confirmed using XRD. Cryomilling, being a solid-state, low-
temperature blending technique eliminates problems such as the use of high temperature, need for 
block copolymers, solvents and the possibility of oxidation [241, 259]. Additionally, results from 
the pilot studies conducted also showed that homogeneous dispersion could be attained even at 
high loading percentages of ceramic particles. This observation was in agreement with the 
observations made by Lim et al. (2014) [48]. PLA and CS have very different polarities and hence 
achieving a compatible blend of these materials poses a challenge [47]. However, cryomilling 
helps decrease the particle size of the dispersed phase and enhances the attractive interaction and 
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thereby helps overcome the challenge of immiscibility. Moreover, when TCP is dissolved in 
solvents for processing, the rheological properties limit its loading, with the occurrence of 
aggregation and delamination [48]. In conclusion, this study reiterates the potential of cryomilling 
in blending materials for the generation of biocomposites. 
 
5.1.2. Fabrication of PLA/CS/TCP Electrospun Membranes  
 Electrospinning was used to generate barrier membranes from the cryomilled 
biocomposites. Electrospinning was chosen as the ideal fabrication technique based on its success 
in regenerative applications [292-296]. TFA was able to act as the common solvent for the purpose 
of fiber generation. The observations from the pilot studies revealed the inability of solvents like 
DCM, DMF, and chloroform to create a solution of the powder composites. This phenomenon was 
attributed to CS’s ionic character in dissolved state and three-dimensional networks of strong 
hydrogen bonds [47].  Based on the visual characterization performed with SEM, it can be 
concluded that the decrease in PLA concentration in the powder composites resulted in thicker 
fibers. This observation was in agreement with the results already reported by Xu et al. (2009) 
[306]. Additionally, the electrospun scaffolds were able to support the growth of MG63 cells when 
tested under in-vitro conditions. In conclusion, this study provides evidence that electrospun 
membrane made out of PLA, CS, and TCP can be used for the purpose of bone regeneration. 
 
5.1.3. In-vitro Studies of Powder and Electrospun Membranes 
 In this study, RAW 264.7 murine macrophages were used to test the cytocompatibility of 
the powder composites in different concentrations (3 µl/ml, 10 µl/ml, 30 µl/ml and 50 µl/ml). 
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CTB® cell viability assay was used to quantitatively analyze cell viability after 24 and 48 h of 
placement in the culture medium. BF microscopy was used to qualitatively evaluate the 
morphology of the macrophages. The results from the cell viability test indicated that the generated 
powder composites were not toxic to cells and hence can be used to fabricate scaffolds for BTE. 
Then, the electrospun membranes were evaluated for their capability to support and enhance the 
growth of MG63 cells. The cell viability of each material was investigated using CTB® cell 
viability assay after 3 and 7 days from cell seeding. CARS was used to perform a live/dead assay 
to qualitatively analyze the ability of the scaffolds to support cell growth. The results from the 
live/dead assay demonstrated the viability of the scaffolds, showing more green cells (viable) than 
red cells (dead). The test also revealed that the cells were viable and metabolically active both after 
3 and 7 days from cell seeding. The cell viability assay also indicated that the scaffolds were 
suitable for growing MG63 cells. The degradation results showed that the addition of CS and TCP 
accelerated the degradation of PLA membranes. In conclusion, this study validated the use of 
cryomilled PLA/CS/TCP biocomposites in scaffold-based GBR. 
 
5.2. Review of Contributions 
In this study, cryomilling was used to successfully generate novel biodegradable polymer-
bioactive ceramic composites for the fabrication of barrier membranes to be used for the 
regeneration of periodontal bone defects. The results of the in vitro cell studies indicated the 
suitability of the biocomposites for regenerative applications. 
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5.3. Future Perspectives 
There is much scope for the development of newer materials and the associated research in BTE. 
A few aspects that need better understanding and stronger validation are listed in this section.  
 Firstly, different compositions of similar composite materials need to be analyzed to 
identify and develop the “ideal” membrane. The validation of such materials can be strengthened 
by testing them in both in-vitro and in vivo environments. Another potential area of research could 
be the evaluation of this composite material for use in additive fabrication techniques. Bioprinting 
of these composites could give researchers a greater control over the morphology and dimensions 
of the scaffold produced. There is also need to understand the influence of cryomilling at a 
microscopic level and structural changes that it imparts to the materials. Moreover, the influence 
of cryomilling time on the cell viability of the materials needs to be explored. The influence of 
membrane geometry on cell viability needs investigation. A multivariate analysis needs to be 
performed to better understand the degradation characteristics of the barrier membranes. 
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∑ ( 𝑥𝑥𝑖𝑖 − 𝑥𝑥 �)2𝑛𝑛𝑖𝑖=1 𝑥𝑥(𝑖𝑖)𝑥𝑥 �𝑎𝑎𝑖𝑖𝑎𝑎𝑖𝑖, 𝑎𝑎𝑖𝑖, … … . ,𝑎𝑎𝑖𝑖)𝑚𝑚𝑇𝑇𝑉𝑉−1� (𝑚𝑚1,𝑚𝑚2, … … … ,𝑚𝑚𝑛𝑛)𝑇𝑇𝑚𝑚𝑖𝑖𝑞𝑞𝑠𝑠 𝑌𝑌𝐴𝐴 − 𝑌𝑌𝐵𝐵𝑆𝑆𝑆𝑆 𝑌𝑌𝐴𝐴𝑌𝑌𝐵𝐵 µl/ml) 
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APPENDIX STATISTICAL ANALYSIS 
In this study, statistical analyses (Two-way ANOVA with post hoc Tukey’s test) were performed 
to assist in evaluating the credibility of the results obtained from the In vitro studies. The analyses 
were carried out with PRISM ver. 7.0 software. For all the tests, values of p<0.05 were taken to 
indicate statistical significance (95% confidence level). This section intends to summarize all the 
details of the statistical analyses that were performed.  
 
1. Analyses for CTB® Cell Viability Assay with RAW 264.7 Murine Macrophages 
The cytotoxicity test was conducted with three samples in each treatment group, they were 
all tested under the same condition within each group, so the measured fluorescence intensity 
values were expected to have the same distribution. The samples were prepared individually and 
tested in individual wells. So, it was assumed that the observed values of fluorescence intensity 
under each treatment were independent and identically distributed random variables. This 
experiment had two independent variables, namely, material composition (A0, A1, A2, and A3) 
and powder concentration (3 µl/ml, 10 µl/ml, 30 µl/ml and 50 µl/ml). The fluorescence intensity 
values obtained from the micro-plate reader was the only dependent variable. 
Three major assumptions needed to be satisfied before the use of a two-way ANOVA test. 
As previously mentioned, the independence of cases assumption was met by preparing and testing 
samples individually. The homogeneity of variance assumption was also checked before 
proceeding with the parametric test. The Shapiro-Wilk W test was used to test for normality of the 
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data as it has been shown to have a higher power in case of small sample sizes in comparison to 
other normality tests [307]. The corresponding null hypothesis was that the fluorescence intensity 
values were normally distributed. Fig. 1 and Fig. 2 show sample results of the Shapiro-Wilk W 
Test for the cytotoxicity tests performed after 24 and 48 h from cell seeding (A1-3 µl/ml 
combination). 
  
 Fig.1. Normality test results for A1-3 µl/ml (24 h)    Fig. 2. Normality test results for A1-3 µl/ml (48 h) 
In the Shapiro-Wilk W Test, the test statistic is calculated using the following equation, 
𝑊𝑊𝑡𝑡 = (∑ 𝑎𝑎𝑖𝑖𝑥𝑥(𝑖𝑖)𝑛𝑛𝑖𝑖=1 )2∑ ( 𝑥𝑥𝑖𝑖−𝑥𝑥 � )2𝑛𝑛𝑖𝑖=1      (A.1) 
In equation A.1, ith ordered statistic in the entire data set is given by𝑥𝑥(𝑖𝑖), 𝑥𝑥 �  is the mean of all 
statistics and 𝑎𝑎𝑖𝑖 is given by equation A.2 as described below, 
(𝑎𝑎𝑖𝑖, 𝑎𝑎𝑖𝑖, … … . ,𝑎𝑎𝑖𝑖) = 𝑚𝑚𝑇𝑇𝑉𝑉−1�𝑚𝑚𝑇𝑇𝑉𝑉−1𝑉𝑉−1𝑚𝑚      (A.2)  
In equation A.2, m is defined as A.3, 
m = (𝑚𝑚1,𝑚𝑚2, … … … ,𝑚𝑚𝑛𝑛)𝑇𝑇      (A.3) 
In A.3, 𝑚𝑚𝑖𝑖 are the expected values of the order statistics of independent and identically distributed 
random variables sampled from the standard normal distribution and in A.2, V is the covariance 
matrix of those order statistics. The value of W lies between zero and one. Small values of W lead 
to the rejection of normality whereas a value closer to one indicates normality of the data. 
When the analysis was conducted, p values less than 0.05 were observed for all the treatment 
combinations, and hence, it was concluded that fluorescence intensity values were normally 
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distributed. Moreover, it also meant that the two-way ANOVA with post hoc Tukey’s test could 
be used to statistically evaluate the difference between the means. In this study, the cells grown in 
the standard medium were used as controls. 
The result of the two-way ANOVA test conducted for the samples cultured for  
24 h is shown below in Fig. 3. The value of p for material composition was 0.0001 which was less 
than the designated Type I error rate of 0.005. Thus, it was concluded that the material composition 
had a considerable influence on the survival of the macrophages. However, the value of p for 
powder concentration was 0.0580. Hence, it was concluded that the concentration of the powder 
did not have a statistically significant influence on the survival of the macrophages. It was also 
seen that the independent variables did not have a statistically significant interaction effect on the 
dependent variable. However, in the case of statistical significance, the Tukey’s test was performed 
to identify the groups that had a significant difference between them. 
 
 
Fig. 3. Two-way ANOVA results for cytotoxicity test with macrophages (24 h) 
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The Tukey’s test conducted for the samples cultured for 24 h revealed that the material 
compositions were statistically different from the control group but otherwise, A0, A1, A2 and A3 
did not differ significantly from each other. Fig. 4 shows the results of the Tukey’s test. The 
Tukey’s test is calculated based on the equation A.4, 
𝑞𝑞𝑠𝑠 = 
𝑌𝑌𝐴𝐴−𝑌𝑌𝐵𝐵
𝑆𝑆𝑆𝑆
       (A.4) 
where 𝑌𝑌𝐴𝐴the larger of the two means being compared is, 𝑌𝑌𝐵𝐵 is the smaller of the two means being 
compared, and SE is the standard error of the data in question. 
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Fig. 4. Tukey’s test results for pairwise comparisons of material compositions (24 h) 
 
Similar analyses were done to analyze the data obtained from samples cultured for 48 h in 
the medium. The results indicated that the material composition had a statistically significant 
influence on the survival and proliferation of macrophages. Further, the value of p for powder 
concentration was also less than 0.05, and hence it was concluded that the concentration of the 
powder also had a statistically significant influence on the macrophages. However, it was seen that 
the independent variables did not have an interaction effect that was statistically significant. The 
Tukey’s test was performed to further analyze to identify the groups that had a statistical difference 
between them. Fig. 5 shows the results obtained from the two-way ANOVA test while Fig. 6 and 
Fig. 7 represent the results obtained from the Tukey’s tests.  
         
Fig. 5. Two-way ANOVA results for cytotoxicity test with macrophages (48 h) 
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Fig. 6. Tukey’s test to identify the statistically differing material compositions (48 h) 
 
The results of the Tukey’s test (Fig. 6) revealed that at some concentrations, certain 
materials differed statistically from the control group. However, there was no difference between 
the different materials used except in one case (A0 vs. A3 at 3 µl/ml). 
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Fig. 7. Tukey’s test to identify the statistically differing powder concentrations (48 h) 
 
The results of the second Tukey’s test (Fig. 7) revealed that in most cases the use of 
different powder concentrations did not have a significant impact on the survival of the 
macrophages except in three cases. 
 
2. Analysis for CTB® Cell Viability Assay with MG63 cells 
The statistical analysis for the study with MG63 cells was conducted the same way as it 
was conducted for the cytotoxicity test with macrophages. In this case, the independent variables 
were material composition and cell culture time. Moreover, it was ensured that the obtained results 
obeyed the three major assumptions of two-way ANOVA. The results of two-way ANOVA 
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revealed that the materials did not have a significant difference between them indicating that the 
materials tested were comparable. However, as expected, there was a significant statistical 
difference between the fluorescence intensity values obtained from the electrospun membranes 
seeded for 3 days and the ones seeded for 7 days (Fig. 8). This result was used to conclude that the 
cells were able to colonize and proliferate with the passage of time. 
 
Fig. 8. Two-way ANOVA results for the electrospun membranes tested with MG63 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
